PD-L2

PD-L2 Overview

English NameProgrammed death-ligand 2Approved Drugs0
Drugs in Clinical Trials3Target SynonymPDCD1LG2,PDL2,Programmed death ligand 2,CD273,Butyrophilin B7-DC,PD-1 ligand 2,B7-DC,BA574F11.2,PDCD1L2,CD273 Antigen,B7DC,Btdc,B7 Dendritic Cell Molecule,PD-1-Ligand 2,PDCD1 ligand 2,Programmed cell death 1 ligand 2
Highest Development StagePhase 3 Clinical
English NameProgrammed death-ligand 2
Target SynonymPDCD1LG2,PDL2,Programmed death ligand 2,CD273,Butyrophilin B7-DC,PD-1 ligand 2,B7-DC,BA574F11.2,PDCD1L2,CD273 Antigen,B7DC,Btdc,B7 Dendritic Cell Molecule,PD-1-Ligand 2,PDCD1 ligand 2,Programmed cell death 1 ligand 2
Approved Drugs0
Drugs in Clinical Trials3
Highest Development StagePhase 3 Clinical

PD-L2 Product List

  • Product Category

    Protein (8)

  • Product Status

    Launched (8)

  • Species

    Human (5)Mouse (3)

  • Tag

    His Tag (2)Fc Tag (2)Mouse IgG Fc Tag (1)His Tag & Avi Tag (2)Fc Tag & Avi Tag (1)

  • Conjugate

    Unconjugated (5)Biotin-labeled (3)

PD-L2 Background

Programmed cell death 1 ligand 2 (PD-L2 or PDCD1 ligand 2) is also known as Butyrophilin B7-DC, CD antigen CD273, which belongs to the immunoglobulin superfamily or BTN/MOG family. The expression of PD-L2 is up-regulated by IFNG/IFN-gamma stimulation in monocytes and induced on dendritic cells grown from peripheral blood mononuclear cells with CSF2 and IL-4. PD-L2 Involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. PD-L2 interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production.

PD-L2 Synonyms

PDL2,PD-L2,Butyrophilin B7-DC,CD273,PDCD1 ligand 2,PDCD1L2,PDCD1LG2

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
IO-120/ IO-103 (IO Biotech)IO-120/IO-103; IO-120+IO-103Phase 2 ClinicalIo Biotech IncLeukemia, Lymphocytic, Chronic, B-Cell
Details
IMGS-001IMGS-001Phase 1 ClinicalThe University Of Texas MD Anderson Cancer CenterSolid tumours; Neoplasms; Triple Negative Breast Neoplasms; Prostatic Neoplasms; Colorectal Neoplasms
Details
IO-120IO-120Io Biotech Aps
Details

Product Reviews

  • Overview
  • Product List
  • Product Reviews
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland